Immune toxicity remains a diagnosis of exclusion, and multidisciplinary collaboration remains the cornerstone for early diagnosis and treatment.
Immunotherapy Shows Promise
Early data from renal cancer dual drug trial reinforces cancer field’s optimism for immunotherapy approaches.